Oscillococcinum (Anas Barbariae Hepatis Et Cordis Extractum K200)

Anas Barbariae Hepatis Et Cordis Extractum K200, the active ingredient in Oscillococcinum, is an animal‑derived homeopathic preparation presented as a 200 K dilution for sublingual use. It is marketed for the relief of occasional flu‑like symptoms in otherwise healthy adults and children.

GNH USA supplies Oscillococcinum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oscillococcinum is used in the context of homeopathic therapy for acute, self‑limiting influenza‑like illness. It is intended to: - Common cold: May reduce the duration of fever and chills. - Seasonal flu: May help lessen the intensity of body aches and fatigue. - Mild viral syndrome: May support faster return to normal daily activities.

Oscillococcinum is generally well tolerated, and most reported reactions are mild.

Common Side Effects: - Mild gastrointestinal discomfort: occasional nausea or stomach upset. - Transient headache: brief episodes of mild head pain. - Local irritation: slight tingling or burning sensation under the tongue. - Allergic‑type skin rash: rare, mild erythema.

Serious or Rare Side Effects: - Anaphylaxis: extremely rare systemic allergic reaction. - Severe urticaria: uncommon hives affecting larger skin areas. - Angio‑edema: rare swelling of lips or face. - Hypotensive episode: very rare drop in blood pressure.

When considering Oscillococcinum, clinicians should be aware of several safety points: - Pregnancy: consult the prescriber if used during pregnancy. - Breastfeeding: advise the prescriber that it may be used if the benefit – risk ratio is favorable. - Pediatric use: dosage form should be adjusted for age and weight as per guidelines. - Concomitant illness: monitor for worsening symptoms or secondary infection in patients with underlying chronic conditions. - Storage: Store at ambient temperature: keep in the original pack and protect from moisture.

Oscillococcarum ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...